Reference values for high-density lipoprotein particle size and volume by dynamic light scattering in a Brazilian population sample and their relationships with metabolic parameters
Carregando...
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
ALEXANDRE, F.
ZAGO, V. H. S.
PANZOLDO, N. B.
PARRA, E. S.
SCHERRER, D. Z.
VENDRAME, F.
GOMES, E. I. L.
MARCATO, P. D.
Citação
CLINICA CHIMICA ACTA, v.442, p.63-72, 2015
Resumo
Background: Current data indicate that the size of high-density lipoprotein (HDL) may be considered an important marker for cardiovascular disease risk. We established reference values of mean HDL size and volume in an asymptomatic representative Brazilian population sample (n = 590) and their associations with metabolic parameters by gender. Methods: Size and volume were determined in HDL isolated from plasma by polyethyleneglycol precipitation of apoB-containing lipoproteins and measured using the dynamic light scattering (DLS) technique. Results: Although the gender and age distributions agreed with other studies, the mean HDL size reference value was slightly lower than in some other populations. Both HDL size and volume were influenced by gender and varied according to age. HDL size was associated with age and HDL-C (total population); non- white ethnicity and CETP inversely (females); HDL-C and PLTP mass (males). On the other hand, HDL volume was determined only by HDL-C (total population and in both genders) and by PLTP mass (males). Conclusions: The reference values for mean HDL size and volume using the DLS technique were established in an asymptomatic and representative Brazilian population sample, as well as their related metabolic factors. HDL-C was a major determinant of HDL size and volume, which were differently modulated in females and in males.
Palavras-chave
Dynamic light scattering, HDL size, HDL volume, Reference values, Metabolic parameters
Referências
- Abeywardena MY, 2003, ATHEROSCLEROSIS, V171, P157, DOI 10.1016/S0021-9150(03)00157-6
- Arsenault BJ, 2010, CLIN CHEM, V56, P789, DOI 10.1373/clinchem.2009.140939
- Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46
- Berg GA, 2001, MENOPAUSE, V8, P51, DOI 10.1097/00042192-200101000-00009
- BURT VL, 1995, HYPERTENSION, V25, P305
- Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013
- CHAPMAN MJ, 1981, J LIPID RES, V22, P339
- Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399
- Cheung MC, 2009, BBA-MOL CELL BIOL L, V1791, P206, DOI 10.1016/j.bbalip.2008.12.010
- Cullen P, 1997, CIRCULATION, V96, P2128
- da Silva IT, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-19
- DIAS VC, 1988, CLIN CHEM, V34, P2322
- DOBIASOVA M, 1992, J LIPID RES, V33, P1411
- Ehnholm C, 1986, Methods Enzymol, V129, P716
- El Harchaoui K, 2009, ANN INTERN MED, V150, P84
- Freedman DS, 2001, METABOLISM, V50, P370, DOI 10.1053/meta.2001.21027
- Freedman DS, 2004, CLIN CHEM, V50, P1189, DOI 10.1373/clinchem.2004.032763
- FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499
- Giribela AH, 2009, INT J GYNECOL OBSTET, V104, P117, DOI 10.1016/j.ijgo.2008.10.001
- GREENFIELD MS, 1980, METABOLISM, V29, P1095, DOI 10.1016/0026-0495(80)90221-8
- Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028
- (IBGE) IBdGeE, 2011, CAR ETN RAC POP
- Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006
- JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032
- Johnson JL, 2004, ATHEROSCLEROSIS, V176, P371, DOI 10.1016/j.atherosclerosis.2004.05.018
- Kivatinitz SC, 1997, J NEUROCHEM, V69, P2102
- Koro CE, 2006, AM HEART J, V151, P755
- KUNITAKE ST, 1992, J LIPID RES, V33, P1807
- Lagrost L, 1996, J BIOL CHEM, V271, P19058
- Lagrost L, 1998, Methods Mol Biol, V110, P231
- Lima ES, 2004, CLIN CHEM, V50, P1086, DOI 10.1373/clinchem.2004.032383
- Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658
- Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060
- Mallol R, 2012, ANAL BIOANAL CHEM, V402, P2407, DOI 10.1007/s00216-011-5705-9
- Mantyselka P, 2012, ATHEROSCLEROSIS, V223, P239, DOI 10.1016/j.atherosclerosis.2012.05.005
- Matthews KA, 2001, STROKE, V32, P1104
- Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181
- Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405
- Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868
- Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X
- O'Neal D, 1998, J LIPID RES, V39, P2086
- PACKARD CJ, 1979, BIOCHIM BIOPHYS ACTA, V572, P269, DOI 10.1016/0005-2760(79)90042-0
- Razavi AE, 2012, J RES MED SCI, V17, P1020
- Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333
- Ross Reagan L, 2008, Curr Cardiol Rev, V4, P309, DOI 10.2174/157340308786349462
- Sakurai T, 2010, ANN CLIN BIOCHEM, V47, P476, DOI 10.1258/acb.2010.010100
- Santos PCJL, 2010, BLOOD CELL MOL DIS, V45, P302, DOI 10.1016/j.bcmd.2010.08.008
- Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105
- Stahlman M, 2013, BBA-MOL CELL BIOL L, V1831, P1609, DOI 10.1016/j.bbalip.2013.07.009
- Sviridov D, 2008, J ATHEROSCLER THROMB, V15, P52
- Toth Peter P, 2012, Vasc Health Risk Manag, V8, P39, DOI 10.2147/VHRM.S22601
- Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394
- Vergeer M, 2010, CIRCULATION, V122, P470, DOI 10.1161/CIRCULATIONAHA.109.912519
- Villard EF, 2012, ARTERIOSCL THROM VAS, V32, P2341, DOI 10.1161/ATVBAHA.112.252841
- Watanabe H, 2006, ARTERIOSCL THROM VAS, V26, P897, DOI 10.1161/01.ATV.0000209577.04246.c0
- WILLIAMS PT, 1993, ARTERIOSCLER THROMB, V13, P1654